Connection
Edward Havranek to Cross-Over Studies
This is a "connection" page, showing publications Edward Havranek has written about Cross-Over Studies.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.011 |
|
|
|
-
Gottlieb SS, Brater DC, Thomas I, Havranek E, Bourge R, Goldman S, Dyer F, Gomez M, Bennett D, Ticho B, Beckman E, Abraham WT. BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Circulation. 2002 Mar 19; 105(11):1348-53.
Score: 0.011